Limitations of therapies exposed
نویسندگان
چکیده
منابع مشابه
Type 2 Diabetes: Limitations of Current Therapies
Type 2 diabetes is a chronic disease associated with numerous microvascular and macrovascular complications. It affects millions of persons worldwide, posing an enormous socioeconomic burden. A growing body of evidence shows that comorbidities are greatly reduced when adequate glycemic control is achieved. Unfortunately, despite the variety of therapies currently available, the majority of pati...
متن کاملCurrent therapies for asthma. Promise and limitations.
Effective treatments for asthma exist, but morbidity and mortality have continued to climb. Many attempts have been made to refine rather than change therapy over the past 20 years. Drugs currently used to treat asthma include beta 2-agonists, glucocorticoids, theophylline, cromones, and anticholinergic agents. For acute, severe asthma, the inhaled beta 2-agonists are the most effective broncho...
متن کاملSuccesses and limitations of targeted therapies in renal cell carcinoma.
Until recently, the standard treatment for metastatic renal cell carcinoma (RCC) was nonspecific immunotherapy based on interleukin-2 or interferon-α. This was associated with a modest survival benefit and with significant clinical toxicities. The understanding of numerous molecular pathways in RCC, including HIF, VEGF, mTOR, and the consecutive use of targeted therapies since the beginning of ...
متن کاملLimitations of rupture forecasting exposed by instantaneously triggered earthquake doublet
Earthquake hazard assessments and rupture forecasts are based on the potential length of seismic rupture and whether or not slip is arrested at fault segment boundaries. Such forecasts do not generally consider that one earthquake can trigger a second large event, near-instantaneously, at distances greater than a few kilometres. Here we present a geodetic and seismological analysis of a magnitu...
متن کاملIntravesical therapies for bladder cancer - indications and limitations.
• Intravesical therapy is a well-established treatment option for non-muscle-invasive bladder cancer (NMIBC). • Choosing the appropriate intravesical agent, schedule and duration of treatment has long been an area of debate. • We review the intravesical agents that are currently used in the management of NMIBC and examine the indications and limitations of their use. • Given the relative high r...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature
سال: 2012
ISSN: 0028-0836,1476-4687
DOI: 10.1038/484044a